Lv1
88 积分 2021-10-14 加入
Abstract 1872: A DLL3/CD3/CD137 trispecific T cell engager shows potent antitumor activity in small cell lung cancer models
15小时前
求助中
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
1天前
已完结
OX40 and OX40L Interaction in Cancer
6个月前
已完结
Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis
6个月前
已完结
345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis
6个月前
已完结
Biological therapies for pediatric atopic dermatitis – a review
6个月前
已完结
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis
6个月前
已完结
The Role of OX40–OX40L Axis in the Pathogenesis of Atopic Dermatitis
6个月前
已完结
Guidelines of care for the management of atopic dermatitis in adults with topical therapies
6个月前
已完结
Establishing Transcription Profile of Psoriasiform Cutaneous In Vitro using HaCaT Cells Stimulated with Combination of Cytokines
6个月前
已完结
皖公网安备34019202002308
